I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 11 studies | 27% ± 7% | |
| epithelial cell | 3 studies | 34% ± 5% | |
| hepatocyte | 3 studies | 33% ± 13% | |
| goblet cell | 3 studies | 31% ± 10% | |
| adipocyte | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 11 studies | 27% ± 7% | |
| epithelial cell | 3 studies | 34% ± 5% | |
| hepatocyte | 3 studies | 33% ± 13% | |
| goblet cell | 3 studies | 31% ± 10% | |
| adipocyte | 3 studies | 21% ± 4% |
Insufficient scRNA-seq data for expression of CCDC125 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1463.51 | 245 / 245 | 100% | 23.99 | 502 / 502 |
| liver | 100% | 1387.13 | 226 / 226 | 100% | 9.25 | 405 / 406 |
| breast | 100% | 814.77 | 459 / 459 | 100% | 18.52 | 1114 / 1118 |
| thymus | 100% | 650.89 | 653 / 653 | 100% | 7.05 | 602 / 605 |
| intestine | 100% | 705.68 | 966 / 966 | 98% | 7.60 | 519 / 527 |
| stomach | 100% | 740.82 | 359 / 359 | 98% | 6.75 | 281 / 286 |
| pancreas | 100% | 581.85 | 327 / 328 | 98% | 6.84 | 175 / 178 |
| lung | 100% | 664.79 | 576 / 578 | 98% | 6.86 | 1128 / 1155 |
| bladder | 100% | 511.48 | 21 / 21 | 97% | 6.87 | 489 / 504 |
| uterus | 100% | 478.83 | 170 / 170 | 97% | 6.98 | 445 / 459 |
| kidney | 100% | 649.44 | 89 / 89 | 93% | 5.74 | 839 / 901 |
| adrenal gland | 100% | 745.90 | 258 / 258 | 93% | 5.35 | 214 / 230 |
| esophagus | 100% | 549.86 | 1445 / 1445 | 93% | 4.34 | 170 / 183 |
| ovary | 100% | 614.66 | 180 / 180 | 92% | 4.15 | 397 / 430 |
| brain | 100% | 416.30 | 2630 / 2642 | 85% | 4.47 | 602 / 705 |
| skin | 100% | 556.93 | 1809 / 1809 | 77% | 3.90 | 365 / 472 |
| adipose | 100% | 503.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 5.50 | 29 / 29 |
| spleen | 100% | 729.77 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.26 | 1 / 1 |
| blood vessel | 99% | 439.26 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 890.42 | 917 / 929 | 0% | 0 | 0 / 0 |
| muscle | 95% | 237.64 | 761 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 6.23 | 42 / 45 |
| heart | 93% | 272.05 | 803 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 66% | 3.35 | 53 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0035024 | Biological process | negative regulation of Rho protein signal transduction |
| GO_2000146 | Biological process | negative regulation of cell motility |
| GO_0090630 | Biological process | activation of GTPase activity |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | CCDC125 |
| Protein name | Coiled-coil domain-containing protein 125 (Protein kenae) Coiled-coil domain containing 125 (Coiled-coil domain-containing protein 125) CCDC125 protein |
| Synonyms | KENAE |
| Description | FUNCTION: May be involved in the regulation of cell migration. . |
| Accessions | ENST00000396499.5 [Q86Z20-1] Q2HJ12 ENST00000383374.6 ENST00000620431.4 [Q86Z20-1] F8W912 ENST00000511257.1 [Q86Z20-2] ENST00000612469.4 [Q86Z20-2] ENST00000396496.7 [Q86Z20-1] Q86Z20 ENST00000619386.1 [Q86Z20-1] ENST00000610685.4 |
